Clinical predictors of special type of esophageal cancer.
Endoscopic ultrasound
Esophageal cancers
Magnifying endoscopy
Journal
Esophagus : official journal of the Japan Esophageal Society
ISSN: 1612-9067
Titre abrégé: Esophagus
Pays: Japan
ID NLM: 101206627
Informations de publication
Date de publication:
07 2023
07 2023
Historique:
received:
26
12
2022
accepted:
31
03
2023
medline:
5
6
2023
pubmed:
11
4
2023
entrez:
10
4
2023
Statut:
ppublish
Résumé
Esophageal cancers with a histological type other than the two major types, squamous cell carcinoma (SCC) and adenocarcinoma, are referred to as "special type of esophageal cancer" (STEC). STEC is rare and difficult to diagnose preoperatively. Therefore, we aimed to clarify the clinicopathological findings of STEC, including magnifying endoscopy with narrow band imaging (ME-NBI). We reviewed 1133 lesions in 936 consecutive cases who underwent endoscopic resection or surgical resection for primary esophageal cancer. Patients were classified into the SCC group and the STEC group, respectively. Factors that predict STEC endoscopically, as well as clinicopathologic features of STEC compared to SCC, were examined. Twenty-eight STECs were diagnosed in 28 patients: 15 with basaloid squamous cell carcinoma, 6 with adenosquamous carcinoma, 4 with mucoepidermoid carcinoma, 1 with carcinosarcoma, 1 with salivary duct-type carcinoma, and 1 with neuroendocrine cell carcinoma. There was significantly more pT1b or deeper cancer (60.7% vs. 12.8%), lymphovascular invasion (50.0% vs. 11.1%) and elevated type (53.6% vs. 16.1%) in the STEC group. The proportion of lesions with type R vessels on ME-NBI was significantly higher in the STEC group (46.4% vs. 3.9%). The STEC group had significantly lower accuracy of ME-NBI for prediction of depth (64.3% vs. 83.5%) and a greater proportion of underestimated lesions (32.1% vs. 9.3%). In the multivariate analysis, the histopathology of STEC was associated with type R vessels on ME-NBI. Type R vessels and submucosal tumor-like elevation might be the clinical predictors of STEC.
Sections du résumé
BACKGROUND
Esophageal cancers with a histological type other than the two major types, squamous cell carcinoma (SCC) and adenocarcinoma, are referred to as "special type of esophageal cancer" (STEC). STEC is rare and difficult to diagnose preoperatively. Therefore, we aimed to clarify the clinicopathological findings of STEC, including magnifying endoscopy with narrow band imaging (ME-NBI).
METHODS
We reviewed 1133 lesions in 936 consecutive cases who underwent endoscopic resection or surgical resection for primary esophageal cancer. Patients were classified into the SCC group and the STEC group, respectively. Factors that predict STEC endoscopically, as well as clinicopathologic features of STEC compared to SCC, were examined.
RESULTS
Twenty-eight STECs were diagnosed in 28 patients: 15 with basaloid squamous cell carcinoma, 6 with adenosquamous carcinoma, 4 with mucoepidermoid carcinoma, 1 with carcinosarcoma, 1 with salivary duct-type carcinoma, and 1 with neuroendocrine cell carcinoma. There was significantly more pT1b or deeper cancer (60.7% vs. 12.8%), lymphovascular invasion (50.0% vs. 11.1%) and elevated type (53.6% vs. 16.1%) in the STEC group. The proportion of lesions with type R vessels on ME-NBI was significantly higher in the STEC group (46.4% vs. 3.9%). The STEC group had significantly lower accuracy of ME-NBI for prediction of depth (64.3% vs. 83.5%) and a greater proportion of underestimated lesions (32.1% vs. 9.3%). In the multivariate analysis, the histopathology of STEC was associated with type R vessels on ME-NBI.
CONCLUSION
Type R vessels and submucosal tumor-like elevation might be the clinical predictors of STEC.
Identifiants
pubmed: 37036546
doi: 10.1007/s10388-023-01003-1
pii: 10.1007/s10388-023-01003-1
doi:
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
484-491Informations de copyright
© 2023. The Author(s) under exclusive licence to The Japan Esophageal Society.
Références
Japanese Classification of Esophageal Cancer. 11th Edition: part I. Esophagus. 2017;14(1):1–36.
doi: 10.1007/s10388-016-0551-7
Lokuhetty D, White VA, Watanabe R, et al. Digestive system tumours. 5th ed. Lyon: International Agency for Research on Cancer; 2019.
Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349(23):2241–52.
doi: 10.1056/NEJMra035010
pubmed: 14657432
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
doi: 10.3322/caac.21492
pubmed: 30207593
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
doi: 10.3322/caac.21262
pubmed: 25651787
Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma. Lancet. 2013;381(9864):400–12.
doi: 10.1016/S0140-6736(12)60643-6
pubmed: 23374478
Tachimori Y, Ozawa S, Numasaki H, et al. Comprehensive Registry of Esophageal Cancer in Japan, 2010. Esophagus. 2017;14(3):189–214.
doi: 10.1007/s10388-017-0578-4
pubmed: 28725168
pmcid: 5486463
Zhang HD, Chen CG, Gao YY, et al. Primary esophageal adenosquamous carcinoma: a retrospective analysis of 24 cases. Dis Esophagus. 2014;27(8):783–9.
doi: 10.1111/dote.12153
pubmed: 24127755
Vos B, Rozema T, Miller RC, et al. Small cell carcinoma of the esophagus: a multicentre Rare Cancer Network study. Dis Esophagus. 2011;24(4):258–64.
doi: 10.1111/j.1442-2050.2010.01133.x
pubmed: 21073624
Chen S, Chen Y, Yang J, et al. Primary mucoepidermoid carcinoma of the esophagus. J Thorac Oncol. 2011;6(8):1426–31.
doi: 10.1097/JTO.0b013e31821cfb96
pubmed: 21587086
Egashira A, Morita M, Kumagai R, et al. Neuroendocrine carcinoma of the esophagus: Clinicopathological and immunohistochemical features of 14 cases. PLoS One. 2017;12(3): e0173501.
doi: 10.1371/journal.pone.0173501
pubmed: 28288180
pmcid: 5348034
Jeene PM, Geijsen ED, Muijs CT, et al. Small cell carcinoma of the esophagus: a nationwide analysis of treatment and outcome at patient level in locoregional disease. Am J Clin Oncol. 2019;42(6):534–8.
doi: 10.1097/COC.0000000000000546
pubmed: 31021827
pmcid: 6554014
Li TJ, Zhang YX, Wen J, et al. Basaloid squamous cell carcinoma of the esophagus with or without adenoid cystic features. Arch Pathol Lab Med. 2004;128(10):1124–30.
doi: 10.5858/2004-128-1124-BSCCOT
pubmed: 15387711
Ni PZ, Yang YS, Hu WP, et al. Primary adenosquamous carcinoma of the esophagus: an analysis of 39 cases. J Thorac Dis. 2016;8(10):2689–96.
doi: 10.21037/jtd.2016.09.59
pubmed: 27867543
pmcid: 5107504
Oguma J, Ozawa S, Kazuno A, et al. Clinicopathological features of superficial basaloid squamous cell carcinoma of the esophagus. Dis Esophagus. 2017;30(12):1–5.
doi: 10.1093/dote/dox076
pubmed: 28881881
Schizas D, Kapsampelis P, Mylonas KM. Adenosquamous carcinoma of the esophagus: a literature review. J Transl Int Med. 2018;6(2):70–3.
doi: 10.2478/jtim-2018-0014
pubmed: 29984200
pmcid: 6032185
Suzuki Y, Nomura K, Matsui A, et al. Long-term outcomes of endoscopic submucosal dissection for special type of esophageal cancer. Dig Dis. 2023. https://doi.org/10.1159/000529590 .
doi: 10.1159/000529590
pubmed: 37231937
Inoue H, Honda T, Yoshida T, et al. Ultra-high magnification endoscopy of the normal esophageal mucosa. Dig Endosc. 1996;8(2):134–8.
doi: 10.1111/j.1443-1661.1996.tb00429.x
Arima M, Tada M, Arima H. Evaluation of microvascular patterns of superficial esophageal cancers by magnifying endoscopy. Esophagus. 2005;2(4):191–7.
doi: 10.1007/s10388-005-0060-6
Inoue H. Magnification endoscopy in the esophagus and stomach. Dig Endosc. 2001;13(s1):S40–1.
doi: 10.1046/j.1443-1661.2001.0130s1S40.x
Oyama T, Inoue H, Arima M, et al. Prediction of the invasion depth of superficial squamous cell carcinoma based on microvessel morphology: magnifying endoscopic classification of the Japan Esophageal Society. Esophagus. 2017;14(2):105–12.
doi: 10.1007/s10388-016-0527-7
pubmed: 28386209
Goda K, Fujisaki J, Ishihara R, et al. Newly developed magnifying endoscopic classification of the Japan Esophageal Society to identify superficial Barrett’s esophagus-related neoplasms. Esophagus. 2018;15(3):153–9.
doi: 10.1007/s10388-018-0623-y
pubmed: 29923024
pmcid: 6021472
Goda K, Takeuchi M, Ishihara R, et al. Diagnostic utility of a novel magnifying endoscopic classification system for superficial Barrett’s esophagus-related neoplasms: a nationwide multicenter study. Esophagus. 2021;18:713–23.
doi: 10.1007/s10388-021-00841-1
pubmed: 34052965
pmcid: 8387266
Kuwano H, Nishimura Y, Oyama T, et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2012 edited by the Japan Esophageal Society. Esophagus. 2015;12(1):1–30.
doi: 10.1007/s10388-014-0465-1
pubmed: 25620903
The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. GastrointestEndosc. 2003;58(6 Suppl):S3–43.
Yachida S, Nakanishi Y, Shimoda T, et al. Adenosquamous carcinoma of the esophagus. Clinicopathologic study of 18 cases. Oncology. 2004;66(3):218–25.
doi: 10.1159/000077998
pubmed: 15218313
Huang Q, Wu H, Nie L, et al. Primary high-grade neuroendocrine carcinoma of the esophagus: a clinicopathologic and immunohistochemical study of 42 resection cases. Am J Surg Pathol. 2013;37(4):467–83.
doi: 10.1097/PAS.0b013e31826d2639
pubmed: 23426118
Huang Q, Shi J, Sun Q, et al. Distal esophageal carcinomas in Chinese patients vary widely in histopathology, but adenocarcinomas remain rare. Hum Pathol. 2012;43(12):2138–48.
doi: 10.1016/j.humpath.2012.02.018
pubmed: 22658274